康护乐小编告诉你厄达替尼国内去哪里买

It is a once-daily oral pan-fibroblast growth factor receptor that blocks the activity of the fibroblast growth factor receptor and is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have genetic mutations or fusions in the FGFR2 or FGFR3 genes. In the phase II study, 32% of patients treated with erdafitinib experienced complete or complete tumor shrinkage, with 2% experiencing complete regression. The average response time is 5.4 months. First approved in 2019, erdafitinib represents the first personalized treatment for patients with metastatic bladder cancer who have predisposing FGFR gene alterations.

Precautions when using erdafitinib:

1. Eye diseases: Erdafitinib can cause central serous retinopathy/retinal pigment epithelial detachment (CSR/RPED). Have eye exams monthly for the first four months of treatment, every 3 months thereafter, and any time visual symptoms occur. Withhold erdafitinib when CSR/RPED occurs and permanently discontinue if there is no response within 4 weeks or if the severity reaches grade 4.

2. Hyperphosphatemia: The increase in blood phosphorus levels is caused by the pharmacodynamic effects of erdafitinib. Monitor serum phosphorus levels and adjust treatment dosage as needed.

3. Embryo-fetal toxicity: Erdafitinib can cause fetal harm. Inform patients of the potential risk to the fetus and use effective contraception.

:

At present, erdafitinib has not been officially launched in China, so there is no display and sales. Domestic patients who need erdafitinib can purchase the version marketed abroad. If you want to buy erdafitinib sold abroad, but it is inconvenient to go abroad, the most reliable way is to purchase it through a regular domestic overseas medical service institution. They will sign a guarantee contract for you, and will mail it to the patient by direct mail without handling the medicine and payment, guaranteeing 100% authenticity!

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: